Publications:

In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells.

International Journal Of Molecular Sciences

Alshiraihi, Ilham M IM; Jarrell, Dillon K DK; Arhouma, Zeyad Z; Hassell, Kelly N KN; Montgomery, Jaelyn J; Padilla, Alyssa A; Ibrahim, Hend M HM; Crans, Debbie C DC; Kato, Takamitsu A TA; Brown, Mark A MA

Publication Date: 2020-12-15

Variant appearance in text: EGF: S55d

PubMed Link: 33333978

Variant Present in the following documents:

• Main text

View BVdb publication page

Design of a modular protein-based MRI contrast agent for targeted application.

Plos One

Grum, Daniel D; Franke, Stefan S; Kraff, Oliver O; Heider, Dominik D; Schramm, Alexander A; Hoffmann, Daniel D; Bayer, Peter P

Publication Date: 2013

Variant appearance in text: EGF: S55D

PubMed Link: 23762349

Variant Present in the following documents:

• Main text
• pone.0065346.pdf

View BVdb publication page